SJS Investment Consulting’s iRadimed IRMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$259 Buy
3
+1
+50% +$90 ﹤0.01% 2896
2026
Q2
$192 Hold
2
– – ﹤0.01% 2483
2026
Q1
$193 Hold
2
– – ﹤0.01% 1990
2025
Q4
$195 Buy
+2
New +$172 ﹤0.01% 1815

Other funds holding IRMD

SJS Investment Consulting's IRMD Position: Q3 2026 in Review

SJS Investment Consulting increased its iRadimed (IRMD) stake by 50% in Q3 2026, buying an estimated $90 and bringing the position to 3 shares worth $259. The position accounts for ﹤0.01% of the portfolio, ranked #2896.

SJS Investment Consulting first reported a position in IRMD in Q4 2025 and has held it in 4 quarters since. 215 funds tracked by Wall St. Rank hold IRMD as of Q3 2026.

  • SJS Investment Consulting held 3 shares of iRadimed worth $259 as of Q3 2026.
  • SJS Investment Consulting bought 1 iRadimed share in Q3 2026, an estimated $90.
  • iRadimed made up ﹤0.01% of SJS Investment Consulting's portfolio in Q3 2026, its #2896 holding.
  • SJS Investment Consulting first reported a position in iRadimed in Q4 2025 and has held it in 4 quarters since.
  • 215 funds tracked by Wall St. Rank held iRadimed as of Q3 2026.

Based on SJS Investment Consulting's 13F filing for Q3 2026, filed 26 Oct 2026.